Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A process for the preparation of entacapone form-A

A technology of cyano group and dihydroxy group, applied in the field of A-type crystallization, can solve the problems such as the type of polytype is not disclosed

Inactive Publication Date: 2009-06-17
ACTAVIS GRP PTC EHF
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Patent Application Publication WO2005 / 063693 A1 describes an improved process for the preparation of entacapone, but does not disclose the type of polytype

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A process for the preparation of entacapone form-A
  • A process for the preparation of entacapone form-A
  • A process for the preparation of entacapone form-A

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Preparation of (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-acrylamide (entacapone).

[0031]3,4-dihydroxy-5-nitrobenzaldehyde (50g), N,N-diethylcyanoacetamide (76.5g), piperidine (19.2g) were loaded into a mixture containing dimethoxyethane (200ml ) and heptane (200ml) in a reaction vessel. The reaction mixture was refluxed for 15-25 hours until the disappearance of starting material (monitored by HPLC). The solvent was distilled off under high vacuum at 70-80°C. Then cool to 25-35°C. To the intermediate product in the flask was added dichloromethane (1.0 L) at 25-35°C. The mixture was stirred at this temperature for 24 hours. It was then filtered, dried and charged to a reaction flask containing methanol. The mixture was treated with activated carbon, filtered and concentrated to obtain the target compound (HPLC 99.78%, Z-isomer content <0.1%) with a yield of 75%.

Embodiment 2

[0033] 3,4-dihydroxy-5-nitrobenzaldehyde (25g), N,N-diethyl cyanoacetamide (38.25g), dibutylamine (10g) were charged into dimethoxyethane (100ml ) and heptane (100ml) in a reaction vessel. The reaction mixture was refluxed for 15-25 hours until the disappearance of starting material (monitored by HPLC). Under high vacuum at 70-80°C, the solvent was distilled off. Then cool to 25-35°C. To the intermediate product in the flask was added dichloromethane (500ml) at 25-35°C. The mixture was stirred at this temperature for 24 hours. Then, it was filtered, washed with water, dried and charged to a reaction flask containing acetonitrile. The mixture was treated with charcoal, filtered and concentrated to give the title compound (HPLC 99.7%, Z-isomer content <0.1%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A process to prepare (2E) -2-cyano-3- (3 , 4-dihydroxy-5-nitrophenyl) -N, N-diethyl-2- propenamide (Entacapone) eliminating corrosive acids in the purification, with more than 99.5 % purity with a Z-isomer content of less than 0.1% comprising condensation of 3, 4-Dihydroxy{5-nitrobenzaldehyde with N,N-diethyl cyanoacetamide in the presence of a base selected from cyclic and acyclic secondary amines and a mixture of solvents, to obtain a crude product, stirring the crude product in a halogenated solvent, filtering and finally crystallization of polymorph A of Entacapone in a solvent.

Description

technical field [0001] The present invention relates to having figure 1 (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrobenzene)-N,N-diethyl-2-acrylamide (INN name is Entacar A new preparation method for stable type A crystals of Entacapone. The method is simple, efficient and suitable for large-scale production. Entacapone is an inhibitor of catechol-O-methyltransferase. Background technique [0002] US Patent No. 4963590 (UK Patent No. 8727854) first disclosed entacapone (molecular formula 1) and its application in inhibiting catechol-O-methyltransferase. The chemical name of entacapone is (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-acrylamide. It is used as an adjuvant to levodopa / carbidopa therapy in the treatment of Parkinson's disease. Parkinson's disease belongs to a class of disorders called motor disorders, which result from a loss of dopamine, which makes brain cells. Catechol-O-methyltransferase (COMT) inhibitors allow large amounts of levodopa to reach ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C253/30
CPCC07C279/22C07C2101/02C07C255/54C07C2601/02
Inventor 格泰姆布·塞瑟莱姆·奇图尔拉觉莱姆·巴帕特·尤德尔加雅玛尼·穆努沙米纳格·维恩卡他·撒特雅·普拉撒纳·恩杰内雅·莱德哈·克里士纳·穆思·穆皮德
Owner ACTAVIS GRP PTC EHF
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products